trial · primary record
ADU-1805
Solid Tumor, Adult
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2027-07 |
| Primary endpoint | Escalation Phase: Incidence and severity of dose limiting toxicity (DLT), treatment-emergent adverse events (TEAEs), and changes from baseline in safety parameters |
| Registry ID | NCT05856981 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:49.408Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05856981
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.